This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To evaluate the safety of escalating doses of the candidated HIV vaccine. to evaluate the immunogenicity of escalating doses of the candidate vaccine.
Showing the most recent 10 out of 515 publications